BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 25749072)

  • 1. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
    Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
    Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
    JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
    Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Nieboer P; van der Hoeven JJM; Smorenburg CH
    Support Care Cancer; 2019 May; 27(5):1919-1925. PubMed ID: 30206728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.
    van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
    Eur J Oncol Nurs; 2013 Oct; 17(5):536-40. PubMed ID: 23571182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
    Smetanay K; Junio P; Feißt M; Seitz J; Hassel JC; Mayer L; Matthies LM; Schumann A; Hennigs A; Heil J; Sohn C; Jaeger D; Schneeweiss A; Marmé F
    Breast Cancer Res Treat; 2019 Jan; 173(1):135-143. PubMed ID: 30255454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy.
    Rice BA; Ver Hoeve ES; DeLuca AN; Esserman LJ; Rugo HS; Melisko ME
    Breast Cancer Res Treat; 2018 Jan; 167(1):117-122. PubMed ID: 28921303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: The Poliambulanza Preliminary Experience.
    Prochilo T; Huscher A; Andreis F; Mirandola M; Zaina E; Pomentale B; Pedrali C; Zanotti L; Mutti S; Zaniboni A
    Rev Recent Clin Trials; 2019; 14(1):66-71. PubMed ID: 30457055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final results of a prospective study of scalp cooling in preventing chemotherapy-induced alopecia.
    Orlando L; Loparco D; Fedele P; Schiavone P; Quaranta A; Caliolo C; Cinefra M; Rizzo P; Calvani N; Morleo A; Varriano R; Bonuso V; Falcone LL; Caloro M; Cinieri S
    Future Oncol; 2019 Oct; 15(29):3337-3344. PubMed ID: 31578891
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
    JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
    Protière C; Evans K; Camerlo J; d'Ingrado MP; Macquart-Moulin G; Viens P; Maraninchi D; Genre D
    Support Care Cancer; 2002 Oct; 10(7):529-37. PubMed ID: 12324807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy.
    Vasconcelos I; Wiesske A; Schoenegg W
    Breast; 2018 Aug; 40():1-3. PubMed ID: 29660543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel.
    Macduff C; Mackenzie T; Hutcheon A; Melville L; Archibald H
    Eur J Cancer Care (Engl); 2003 Jun; 12(2):154-61. PubMed ID: 12787013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.
    Ohsumi S; Kiyoto S; Takahashi M; Hara F; Takashima S; Aogi K; Matsuda M; Yamamura N; Doi M
    Support Care Cancer; 2021 Jan; 29(1):437-443. PubMed ID: 32388615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment.
    Betticher DC; Delmore G; Breitenstein U; Anchisi S; Zimmerli-Schwab B; Müller A; von Moos R; Hügli-Dayer AM; Schefer H; Bodenmann S; Bühler V; Trueb RR
    Support Care Cancer; 2013 Sep; 21(9):2565-73. PubMed ID: 23636645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
    Giarratano T; Frezzini S; Zanocco M; Giorgi CA; Mioranza E; Miglietta F; Griguolo G; Falci C; Faggioni G; Tasca G; Di Liso E; Vernaci G; Menichetti A; Mantiero M; Grosso D; Guarneri V; Dieci MV
    Breast J; 2020 Jul; 26(7):1296-1301. PubMed ID: 31837103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scalp cooling in breast cancer patients treated with docetaxel-cyclophosphamide: patient- and nurse-reported results.
    Coolbrandt A; T'Jonck A; Blauwens K; Dejaeger E; Neven P; Punie K; Vancoille K; Wildiers H
    Breast Cancer Res Treat; 2021 Apr; 186(3):715-722. PubMed ID: 33452953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients - results from the Dutch Scalp Cooling Registry.
    Heibloem RE; Komen MMC; Ilozumba OUC; van den Hurk CJG
    Support Care Cancer; 2023 Apr; 31(5):273. PubMed ID: 37067605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.
    Komen MM; Breed WP; Smorenburg CH; van der Ploeg T; Goey SH; van der Hoeven JJ; Nortier JW; van den Hurk CJ
    Support Care Cancer; 2016 Jun; 24(6):2735-41. PubMed ID: 26805558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.
    Tollenaar RA; Liefers GJ; Repelaer van Driel OJ; van de Velde CJ
    Eur J Cancer; 1994; 30A(10):1448-53. PubMed ID: 7833100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial.
    Lugtenberg RT; van den Hurk CJG; Smorenburg CH; Mosch L; Houtsma D; Deursen MAGDH; Kaptein AA; Gelderblom H; Kroep JR
    Support Care Cancer; 2022 Aug; 30(8):6641-6648. PubMed ID: 35501515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.